[1]汤铭杰,张磊,王勇,等.锥形束CT成像技术在肝恶性肿瘤血管介入治疗中的应用及其研究进展 [J].介入放射学杂志,2024,33(12):1360-1366.
　TANG Mingjie,ZHANG Lei,WANG Yong,et al.Cone-beam CT technique：its application in endovascular interventional treatment of hepatic malignancy and its research progress[J].journal interventional radiology,2024,33(12):1360-1366.

点击复制

锥形束CT成像技术在肝恶性肿瘤血管介入治疗中的应用及其研究进展
(/HTML)

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］Zheng RS，Zhang SW，Zeng HM，et al.Cancer incidence and mortality in China，2016［J］.J Natl Cancer Cent 2022，2：1-9.
［2］Forner A，Reig M，Bruix J.Hepatocellular carcinoma［J］.Lancet，2018，391：1301-1314.
［3］Zhu HD，Li HL，Huang MS，et al.Transarterial chemoembolization with PD-（L）1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma （CHANCE001）［J］.Signal Transduct Target Ther，2023，8：58.
［4］Aliseda D，Marti-Cruchaga P，Zozaya G，et al.Liver resection and transplantation following yttrium-90 radioembolization for primary malignant liver tumors：a 15-year single-center experience［J］.Cancers （Basel），2023，15：733.
［5］Alsultan AA，Braat AJAT，Smits MLJ，et al.Current status and future direction of hepatic radioembolisation［J］.Clin Oncol （R Coll Radiol），2021，33：106-116.
［6］Orth RC，Wallace MJ，Kuo MD，et al.C-arm cone-beam CT：general principles and technical considerations for use in interventional radiology［J］.J Vasc Interv Radiol，2009，20：S538-S544..
［7］Jaffray DA，Siewerdsen JH，Wong JW，et al.Flat-panel cone-beam computed tomography for image-guided radiation therapy［J］.Int J Radiat Oncol Biol Phys，2002，53：1337-1349.
［8］傅开元，张万林，柳登高，等.应用锥形束CT诊断颞下颌关节骨关节病的探讨［J］.中华口腔医学杂志，2007，42：417-420.
［9］杨凯，张学贤，李自恒，等.C臂CT在颅内动脉瘤诊疗中研究进展［J］.介入放射学杂志，2022，31：109-112.
［10］Li TF，Ma J，Han XW，et al.Application of high-resolution C-arm CT combined with streak metal artifact removal technology for the stent-assisted embolization of intracranial aneurysms［J］.Am J Neuroradiol，2019，40：1752-1758.
［11］中国医师协会介入医师分会临床诊疗指南专委会.中国肝细胞癌经动脉化疗栓塞（TACE）治疗临床实践指南（2023年版）［J］.中华医学杂志，2023，103：2674-2694.
［12］Lu J，Zhao M，Arai Y，et al.Clinical practice of transarterial chemoembolization for hepatocellular carcinoma：consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology （ISMIO）［J］.Hepatobiliary Surg Nutr，2021，10：661-671.
［13］王为.锥形束CT在放射治疗中的应用［J］.中国医学影像技术，2011，27：1074-1077.
［14］Feldkamp LA，Davis LC，Kress JW.Practical cone-beam algorithm［J］.J Opt Soc Am A，1984，1：612.
［15］Tacher V，Radaelli A，Lin M，et al.How I do it：cone-beam CT during transarterial chemoembolization for liver cancer［J］.Radiology，2015，274：320-334.
［16］Koelblinger C，Schima W，Berger-Kulemann V，et al.C-arm CT during hepatic arteriography tumour-to-liver contrast：intraindividual comparison of three different contrast media application protocols［J］.Eur Radiol，2013，23：938-942.
［17］孔铭新，于曰俊，马飞飞，等.锥形束CT双期扫描在肝恶性肿瘤介入治疗中的应用［J］.介入放射学杂志，2019，28：38-41.
［18］Pung L，Ahmad M，Mueller K，et al.The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma：a systematic review and meta-analysis［J］.J Vasc Interv Radiol，2017，28：334-341.
［19］Jonczyk M，Collettini F，Schnapauff D，et al.Visibility of hypovascularized liver tumors during intra-arterial therapy using split-bolus single-phase cone beam CT［J］.Cardiovasc Intervent Radiol，2019，42：260-267.
［20］Wang C，Wang Q，Chen W，et al.DYNA CT arteriographic evaluation of hepatocellular carcinoma for treatment by trans-catheter arterial chemoembolization［J］.Int J Clin Exp Med，2015，8：20548-20555.
［21］Iwazawa J，Ohue S，Mitani T，et al.Identifying feeding arteries during TACE of hepatic tumors：comparison of C-arm CT and digital subtraction angiography［J］.Am J Roentgenol，2009，192：1057-1063.
［22］Bannangkoon K，Hongsakul K，Tubtawee T.Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization［J］.BMC Gastroenterol，2021，21：419.
［23］Iwazawa J，Ohue S，Hashimoto N，et al.Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma［J］.Eur J Radiol，2012，81：3985-3992.
［24］Lee JH，Lee IJ，Kim HB，et al.Efficacy and safety of transarterial chemoembolisation with cone-beam CT in patients with hepatocellular carcinoma within the Milan criteria：a retrospective cohort study［J］.Clin Radiol，2019，74：407.e19-407.e28.
［25］Miyayama S，Yamashiro M，Hashimoto M，et al.Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography［J］.Cardiovasc Intervent Radiol，2014，37：388-395.
［26］Wong SY，Foley S，Cantwell CP，et al.The effects of cone-beam computed tomography imaging guidance on patient radiation exposures in trans-arterial chemoembolisation for hepatocellular carcinoma［J］.Radiat Prot Dosimetry，2022，198：441-447.
［27］Hidajat N，Wust P，Felix R，et al.Radiation exposure to patient and staff in hepatic chemoembolization：risk estimation of cancer and deterministic effects［J］.Cardiovasc Intervent Radiol，2006，29：791-796.
［28］Yao X，Yan D，Jiang X，et al.Dual-phase cone-beam CT-based navigation imaging significantly enhances tumor detectability and aids superselective transarterial chemoembolization of liver cancer［J］.Acad Radiol，2018，25：1031-1037.
［29］Kothary N，Abdelmaksoud MH，Tognolini A，et al.Imaging guidance with C-arm CT：prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization［J］.J Vasc Interv Radiol，2011，22：1535-1543.
［30］Lucatelli P，De Rubeis G，Basilico F，et al.Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC，in course of degradable starch microsphere TACE［J］.Radiol Med，2019，124：1212-1219.
［31］Lucatelli P，De Rubeis G，Ginnani Corradini L，et al.Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure［J］.Eur J Radiol，2020，124：108806.
［32］Cho Y，Lee S，Park SJ.Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization［J］.PLoS One，2021，16：e0245911.
［33］Tacher V，Lin MD，Chao M，et al.Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma：comparison between C-arm cone beam computed tomography and MRI［J］.Acad Radiol，2013，20：446-452.
［34］Wang X，Yarmohammadi H，Cao G，et al.Dual phase cone-beam computed tomography in detecting ＜3 cm hepatocellular carcinomas during transarterial chemoembolization［J］.J Cancer Res Ther，2017，13：38-43.
［35］Schernthaner RE，Haroun RR，Duran R，et al.Improved visibility of metastatic disease in the liver during intra-arterial therapy using delayed arterial phase cone-beam CT［J］.Cardiovasc Intervent Radiol，2016，39：1429-1437.
［36］Pichon E，Bekes G，Deschamps F，et al.Development and preliminary evaluation of software for planning selective liver embolizations from three-dimensional rotational fluoroscopy imaging［J］.Int J Comput Assist Radiol Surg，2008，3：405-412.
［37］Cui Z，Shukla PA，Habibollahi P，et al.A systematic review of automated feeder detection software for locoregional treatment of hepatic tumors［J］.Diagn Interv Imaging，2020，101：439-449.
［38］Chiaradia M，Izamis ML，Radaelli A，et al.Sensitivity and reproducibility of automated feeding artery detection software during transarterial chemoembolization of hepatocellular carcinoma［J］.J Vasc Interv Radiol，2018，29：425-431.
［39］Miyayama S，Yamashiro M，Nagai K，et al.Efficacy of automated tumor-feeder detection software using cone-beam computed tomography technology in transarterial embolization through extrahepatic collateral vessels for malignant hepatic tumors［J］.Hepatol Res，2016，46：166-173.
［40］Miyayama S，Yamashiro M，Ikeda R，et al.Usefulness of virtual parenchymal perfusion software visualizing embolized areas to determine optimal catheter position in superselective conventional transarterial chemoembolization for hepatocellular carcinoma［J］.Hepatol Res，2021，51：313-322.
［41］Derbel H，Kobeiter H，Pizaine G，et al.Accuracy of a cone-beam CT virtual parenchymal perfusion algorithm for liver cancer targeting during intra-arterial therapy［J］.J Vasc Interv Radiol，2018，29：254-261.e2.
［42］Miyayama S，Yamashiro M，Nagai K，et al.Performance of novel virtual parenchymal perfusion software visualizing embolized areas of transcatheter arterial chemoembolization for hepatocellular carcinoma［J］.Hepatol Res，2017，47：446-454.
［43］Kinoshita M，Takechi K，Arai Y，et al.Utility of the virtual liver parenchymal perfusion area using a commercially available workstation in transarterial chemoembolization for hepatocellular carcinoma［J］.Cardiovasc Intervent Radiol，2019，42：69-77.
［44］Kim KA，Choi SY，Kim MU，et al.The efficacy of cone-beam CT-based liver perfusion mapping to predict initial response of hepatocellular carcinoma to transarterial chemoembolization［J］.J Vasc Interv Radiol，2019，30：358-369.
［45］Choi SY，Kim KA，Choi W，et al.Usefulness of cone-beam CT-based liver perfusion mapping for evaluating the response of hepatocellular carcinoma to conventional transarterial chem-oembolization［J］.J Clin Med，2021，10：713.
［46］Li Z，Jiao D，Si G，et al.Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion［J］.Int J Hyperthermia，2021，38：428-436.
［47］Tsai YC，Shih JH，Hwang HE，et al.Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization［J］.Eur Radiol，2021，31：7464-7475.
［48］Fronda M，Mistretta F，Calandri M，et al.The role of immediate post-procedural cone-beam computed tomography （CBCT） in predicting the early radiologic response of hepatocellular carcinoma （HCC） nodules to drug-eluting bead transarterial chemoembolization （DEB-TACE）［J］.J Clin Med，2022，11：7089.
［49］Stein SI，Soliman M，Sparapani J，et al.Conventional hepatic volumetry May Lead to inaccurate segmental yttrium-90 radiation dosimetry［J］.Cardiovasc Intervent Radiol，2021，44：1973-1985.
［50］O′Connor PJ，Pasik SD，van der Bom IM，et al.Feasibility of yttrium-90 radioembolization dose calculation utilizing intra-procedural open trajectory cone beam CT［J］.Cardiovasc Intervent Radiol，2020，43：295-301.
［51］Schernthaner RE，Chapiro J，Sahu S，et al.Feasibility of a modified cone-beam CT rotation trajectory to improve liver periphery visualization during transarterial chemoembolization［J］.Radiology，2015，277：833-841.
［52］Hatamikia S，Biguri A，Herl G，et al.Source-detector trajectory optimization in cone-beam computed tomography：a comprehensive review on Today′s state-of-the-art［J］.Phys Med Biol，2022，67：16TR03.
［53］Kwon LM，Hwang JS，Lee YS，et al.A motion artifact correction algorithm for cone-beam CT in patients with hepatic malignancies treated with transarterial chemoembolization［J］.J Vasc Interv Radiol，2022，33：1367-1374.
［54］Becker LS，Dewald CLA，von Falck C，et al.Effectuality study of a 3D motion correction algorithm in C-arm CTs of severely impaired image quality during transarterial chemoembolization［J］.Cancer Imaging，2022，22：37.
［55］de Baere T，Ronot M，Chung JW，et al.Initiative on superselective conventional transarterial chemoembolization results （INSPIRE）［J］.Cardiovasc Intervent Radiol，2022，45：1430-1440.